查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765398

全球实验室晶片市场

Lab-on-a-Chip
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，美国实验室晶片市场规模将达到 142 亿美元

全球实验室晶片市场规模预计在2024年为83亿美元，预计到2030年将达到142亿美元，2024年至2030年的复合年增长率为9.4%。作为报告分析的细分市场之一，仪器市场预计将以10.0%的复合年增长率成长，并在分析期结束时达到80亿美元。试剂和耗材市场在分析期间的复合年增长率预计为9.3%。

美国市场规模预估为 23 亿美元，中国市场预估复合年增率为 8.8%

美国实验室晶片市场规模预计在2024年达到23亿美元。作为世界第二大经济体，中国预计在2030年达到22亿美元的市场规模，在2024年至2030年的分析期间内，复合年增长率为8.8%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个国家的复合年增长率分别为8.8%和7.5%。在欧洲，预计德国的复合年增长率约为7.5%。

全球实验室晶片市场—主要趋势与驱动因素摘要

实验室晶片将如何彻底改变诊断？

实验室晶片(LOC) 技术正在革新诊断技术，它使复杂的检测流程能够在紧凑的微流体晶片上进行。这些设备将多种检测功能（包括样品製备、检测和数据分析）整合到单一晶片上，从而提供快速、准确且经济高效的诊断解决方案。 LOC 系统尤其适用于照护现场(POC)，例如急诊和远距医疗机构，在这些情况下，快速获得结果对于及时决策至关重要。能够快速检测生物标记、病原体和基因突变的实验室晶片设备正在推动医疗诊断向更有效率、更便捷的方向转变，这些诊断可以在需要时进行，而无需在中心实验室进行。

为什么个人化医疗和基因组学推动了对实验室晶片的需求？

个人化医疗和基因组学的兴起极大地推动了对实验室晶片设备的需求，这些设备是进行精准、针对患者的诊断的理想选择。个人化医疗着重于根据个别基因图谱制定个人化治疗方案，这需要快速可靠的基因资讯分析。实验室晶片技术使PCR和DNA测序等复杂的基因组分析实现微型化和自动化，与传统方法相比，减少了所需的时间和资源。随着个人化医疗在肿瘤学和罕见疾病管理等领域的日益普及，晶片实验室设备正成为提供针对性医疗保健解决方案的重要工具，使在患者层面进行高阶诊断变得更加可行。

小型化和便携性如何影响研究和诊断？

微型化和便携性是实验室晶片技术的核心优势，使其能够广泛应用于研究实验室、现场诊断和资源有限的环境中。晶片实验室设备体积小巧，便于携带各种先进的检测功能，从分子生物学实验到病原体检测，从而方便在缺乏完整实验室基础设施的地区进行诊断。这些设备在偏远和资源匮乏的环境中尤其有益，因为它们可以用最少的样品和试剂量进行分析，从而降低成本并减少废弃物。此外，微流体系统和感测器与数位连接的整合实现了即时数据传输，从而实现了远端监控和云端基础的数据分析，从而增强诊断和研究洞察力。

推动实验室晶片市场成长的因素是什么？

实验室晶片市场的成长受到多种因素的推动，包括快速诊断的需求、个人化医疗的进步以及对可携式和微型实验室系统日益增长的需求。医疗保健领域，尤其是在照护现场，对快速且准确的诊断的需求正在推动晶片实验室技术的普及。个人化医疗的转变需要精准的基因和分子分析，这也加速了晶片实验室技术的普及，尤其是在肿瘤学和基因检测等领域。此外，便携性和极低的资源需求使其成为偏远地区和资源受限环境的理想选择，从而扩大了其市场覆盖范围。总而言之，这些因素支持实验室晶片市场的扩张，以高效、精准地满足现代医疗保健和研究需求。

部分

应用（基因组学和蛋白​​质组学、诊断学、药物发现、其他应用）、细分市场（仪器、试剂和耗材、软体和服务）

受访公司范例

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • IDEX Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP16526

Global Lab-on-a-Chip Market to Reach US$14.2 Billion by 2030

The global market for Lab-on-a-Chip estimated at US$8.3 Billion in the year 2024, is expected to reach US$14.2 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$8.0 Billion by the end of the analysis period. Growth in the Reagents & Consumables segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.8% CAGR

The Lab-on-a-Chip market in the U.S. is estimated at US$2.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Lab-on-a-Chip Market - Key Trends & Drivers Summarized

How Is Lab-on-a-Chip Revolutionizing Diagnostics?

Lab-on-a-chip (LOC) technology is transforming diagnostics by enabling complex laboratory processes to be performed on a compact, microfluidic chip. These devices integrate multiple laboratory functions, such as sample preparation, detection, and data analysis, onto a single chip, offering fast, accurate, and cost-effective diagnostic solutions. LOC systems are particularly valuable in point-of-care (POC) diagnostics, where rapid results are essential for timely decision-making, such as in emergency rooms or remote healthcare settings. With the ability to detect biomarkers, pathogens, and genetic mutations quickly, lab-on-a-chip devices are driving a shift toward more efficient, accessible healthcare diagnostics that can be administered at the point of need rather than in centralized laboratories.

Why Are Personalized Medicine and Genomics Driving Demand for Lab-on-a-Chip?

The rise of personalized medicine and genomics is significantly boosting the demand for lab-on-a-chip devices, which are ideal for precise, patient-specific diagnostics. Personalized medicine focuses on tailoring treatments based on individual genetic profiles, requiring rapid and reliable analysis of genetic information. Lab-on-a-chip technology allows for the miniaturization and automation of complex genomic analyses, such as PCR and DNA sequencing, reducing time and resource requirements compared to traditional methods. As personalized medicine gains traction in fields like oncology and rare disease management, LOC devices are becoming essential tools for delivering targeted healthcare solutions, making advanced diagnostics more feasible at the patient level.

How Is Miniaturization and Portability Impacting Research and Diagnostics?

Miniaturization and portability are central advantages of lab-on-a-chip technology, enabling its widespread adoption in research labs, field diagnostics, and resource-limited settings. The compact size of LOC devices allows for the portability of sophisticated testing capabilities, from molecular biology experiments to pathogen detection, facilitating diagnostics in locations without full laboratory infrastructure. These devices can perform analyses with minimal sample and reagent volumes, reducing costs and waste, which is particularly beneficial in remote and low-resource settings. Additionally, the integration of microfluidic systems and sensors with digital connectivity allows real-time data transfer, enabling remote monitoring and cloud-based data analysis for enhanced diagnostics and research insights.

What Drives the Growth of the Lab-on-a-Chip Market?

The growth in the lab-on-a-chip market is driven by several factors, including the demand for rapid diagnostics, advancements in personalized medicine, and the increasing need for portable, miniaturized lab systems. The need for fast and accurate diagnostics in healthcare, especially in point-of-care and emergency settings, is propelling the adoption of LOC technology. The shift toward personalized medicine, which requires precise genetic and molecular analysis, is also accelerating LOC usage, especially in fields like oncology and genetic testing. Furthermore, the advantages of portability and minimal resource requirements make LOC systems ideal for remote and resource-limited settings, expanding their market reach. These factors collectively support the lab-on-a-chip market’s expansion as it addresses modern healthcare and research needs with efficiency and precision.

SCOPE OF STUDY:

The report analyzes the Lab-on-a-Chip market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Genomics & Proteomics, Diagnostics, Drug Discovery, Other Applications); Segment (Instruments, Reagents & Consumables, Software & Services)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 16 Featured) -

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fluidigm Corporation
  • IDEX Corporation
  • PerkinElmer, Inc.
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Lab-on-a-Chip - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Miniaturized Diagnostics and Point-of-Care Testing
    • Growth in Personalized Medicine Driving Demand for Lab-on-a-Chip Solutions
    • Advancements in Microfluidics Technology Enhancing Chip Capabilities
    • Expansion of Applications in Genomics and Proteomics Research
    • Rising Use of Lab-on-a-Chip Devices in Infectious Disease Diagnosis
    • Increased Adoption in Drug Discovery and Development Processes
    • Growing Demand for Cost-Effective and Rapid Diagnostic Solutions
    • Development of Multi-Analyte Detection Chips for Comprehensive Testing
    • Higher Investment in Lab-on-a-Chip R&D by Pharmaceutical Companies
    • Growth of Wearable and Implantable Lab-on-a-Chip Devices for Monitoring
    • Expansion of Lab-on-a-Chip in Food Safety and Environmental Testing
    • Integration of AI and Big Data in Lab-on-a-Chip for Enhanced Analytics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Lab-on-a-Chip Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Genomics & Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Genomics & Proteomics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • CHINA
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Lab-on-a-Chip by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Lab-on-a-Chip Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Segment - Instruments, Reagents & Consumables and Software & Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Lab-on-a-Chip by Segment - Percentage Breakdown of Value Sales for Instruments, Reagents & Consumables and Software & Services for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Lab-on-a-Chip by Application - Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Lab-on-a-Chip by Application - Percentage Breakdown of Value Sales for Genomics & Proteomics, Diagnostics, Drug Discovery and Other Applications for the Years 2025 & 2030

IV. COMPETITION